Q4 2024 Earnings Call Transcript March 5, 2025 EyePoint Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS ...

WASHINGTON-President Trump put his disruptive return to power on full display during a prime-time address to Congress, offering a no-apologies assessment of his decisions to crack down on illegal ...

An interesting thread running through the current narrative is a bit intellectual and structural for my liking, but still ...

JNJ's $14B acquisition of ITCI bolsters its portfolio with Caplyta, showing strong sales and patent protection until 2033.

Reliance Industries has slipped below the crucial ₹1,200 mark, leaving investors anxious about its future trajectory. After a ...

That, in all statistical likelihood, will probably be our Finals matchup. But doubt the reigning NBA champion Boston Celtics at your own risk. And even if they have some drawbacks that should give ...

Technical indicators suggest that Nvidia stock is facing the threat of a sustained correction in the near future.

Novo Nordisk will slash the price of its blockbuster weight-loss drug Wegovy for cash-paying patients, after American rival ...

Mounting competition in the sector and rising obesity have led the pharmaceutical company to start selling the drug directly ...

President Donald Trump on Tuesday will address Congress for the first time in his second term, and he’ll do with an economy ...

Also in today’s newsletter, Singapore’s DBS expands wealth management business, and Seven & i set to list North American ...

Sarepta Therapeutics hits 52-week lows despite strong earnings and growth. Read why investors should view SRPT as a high risk ...